Lantheus CEO Mary Anne Heino (L) and Perspective Therapeutics CEO Thijs Spoor
Lantheus hands Perspective Therapeutics $28M upfront to expand its radiopharma options
Radiopharma company Lantheus is looking to build up its portfolio through a collaboration with Perspective Therapeutics. By handing Perspective $28 million upfront, Lantheus has the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.